Skip to content

Natera, Inc. NTRA Gross Profit

Discontinued — last reported Q2 '20

Gross Profit at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$137.6M+2.5%
Labcorp Holdings logo
Labcorp HoldingsLH
$1.01B+6.9%
NeoGenomics logo
NeoGenomicsNEO
$80.86M+10.4%
Illumina logo
IlluminaILMN
$721M+5.6%
Veracyte logo
VeracyteVCYT
$101.16M+27.2%
Quest Diagnostics logo
Quest DiagnosticsDGX

Segments

By segment

See full
Reportable Segment$450.83M

Other financials

Income statement

See full
Revenue$696.6M+38.8%
Operating income-$93.5M-18.1%
Net income-$85.1M-27.1%
EPS (diluted)-$0.60-20.0%

Balance sheet

See full
Cash & equivalents$1.1B+11.7%
Total debt$240.1M+22.7%
Total equity$1.8B+43.1%
Total assets$2.6B+50.9%

Cash flow

See full
Operating cash flow$40.2M-9.6%
CapEx$22.1M+1.5%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$37.51B+59.8%
Enterprise value$36.66B+61.8%
P/S15×+3.1×

Profitability

See full
Gross margin42.9%
Operating margin-13%+0.6pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.9×

Where this comes from

Calculated from Natera, Inc.’s reported figures.

The official record: Natera, Inc.’s 10-Q, filed August 6, 2021, on SEC EDGAR. View the filing →

Questions, answered.

What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.